238 related articles for article (PubMed ID: 31247672)
1. Gabapentin alleviates chronic spontaneous pain and acute hypoxia-related pain in a mouse model of sickle cell disease.
Sadler KE; Langer SN; Menzel AD; Moehring F; Erb AN; Brandow AM; Stucky CL
Br J Haematol; 2019 Oct; 187(2):246-260. PubMed ID: 31247672
[TBL] [Abstract][Full Text] [Related]
2. Peripheral transient receptor potential vanilloid type 4 hypersensitivity contributes to chronic sickle cell disease pain.
Ehlers VL; Sadler KE; Stucky CL
Pain; 2023 Aug; 164(8):1874-1886. PubMed ID: 36897169
[TBL] [Abstract][Full Text] [Related]
3. Mouse Models of Pain in Sickle Cell Disease.
Sagi V; Song-Naba WL; Benson BA; Joshi SS; Gupta K
Curr Protoc Neurosci; 2018 Oct; 85(1):e54. PubMed ID: 30265442
[TBL] [Abstract][Full Text] [Related]
4. Transient receptor potential vanilloid 1 mediates pain in mice with severe sickle cell disease.
Hillery CA; Kerstein PC; Vilceanu D; Barabas ME; Retherford D; Brandow AM; Wandersee NJ; Stucky CL
Blood; 2011 Sep; 118(12):3376-83. PubMed ID: 21708890
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-induced acute lung injury in murine models of sickle cell disease.
Pritchard KA; Ou J; Ou Z; Shi Y; Franciosi JP; Signorino P; Kaul S; Ackland-Berglund C; Witte K; Holzhauer S; Mohandas N; Guice KS; Oldham KT; Hillery CA
Am J Physiol Lung Cell Mol Physiol; 2004 Apr; 286(4):L705-14. PubMed ID: 12972407
[TBL] [Abstract][Full Text] [Related]
6. Quercetin Completely Ameliorates Hypoxia-Reoxygenation-Induced Pathophysiology Severity in NY1DD Transgenic Sickle Mice: Intrinsic Mild Steady State Pathophysiology of the Disease in NY1DD Is Also Reversed.
Thangaswamy S; Branch CA; Ambadipudi K; Acharya SA
Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680105
[TBL] [Abstract][Full Text] [Related]
7. CaMKIIα underlies spontaneous and evoked pain behaviors in Berkeley sickle cell transgenic mice.
He Y; Chen Y; Tian X; Yang C; Lu J; Xiao C; DeSimone J; Wilkie DJ; Molokie RE; Wang ZJ
Pain; 2016 Dec; 157(12):2798-2806. PubMed ID: 27842048
[TBL] [Abstract][Full Text] [Related]
8. PKCδ-targeted intervention relieves chronic pain in a murine sickle cell disease model.
He Y; Wilkie DJ; Nazari J; Wang R; Messing RO; DeSimone J; Molokie RE; Wang ZJ
J Clin Invest; 2016 Aug; 126(8):3053-7. PubMed ID: 27348590
[TBL] [Abstract][Full Text] [Related]
9. Endothelin type A receptors mediate pain in a mouse model of sickle cell disease.
Lutz BM; Wu S; Gu X; Atianjoh FE; Li Z; Fox BM; Pollock DM; Tao YX
Haematologica; 2018 Jul; 103(7):1124-1135. PubMed ID: 29545351
[TBL] [Abstract][Full Text] [Related]
10. Cold exposure induces vaso-occlusion and pain in sickle mice that depend on complement activation.
Ivy ZK; Belcher JD; Khasabova IA; Chen C; Juliette JP; Abdulla F; Ruan C; Allen K; Nguyen J; Rogness VM; Beckman JD; Khasabov SG; Gupta K; Taylor RP; Simone DA; Vercellotti GM
Blood; 2023 Nov; 142(22):1918-1927. PubMed ID: 37774369
[TBL] [Abstract][Full Text] [Related]
11. Mouse models for studying pain in sickle disease: effects of strain, age, and acuteness.
Cain DM; Vang D; Simone DA; Hebbel RP; Gupta K
Br J Haematol; 2012 Feb; 156(4):535-44. PubMed ID: 22171826
[TBL] [Abstract][Full Text] [Related]
12. Gabapentin prevents synaptogenesis between sensory and spinal cord neurons induced by thrombospondin-4 acting on pre-synaptic Ca
Yu YP; Gong N; Kweon TD; Vo B; Luo ZD
Br J Pharmacol; 2018 Jun; 175(12):2348-2361. PubMed ID: 29338087
[TBL] [Abstract][Full Text] [Related]
13. Topical gabapentin gel alleviates allodynia and hyperalgesia in the chronic sciatic nerve constriction injury neuropathic pain model.
Shahid M; Subhan F; Ahmad N; Ali G; Akbar S; Fawad K; Sewell RD
Eur J Pain; 2017 Apr; 21(4):668-680. PubMed ID: 27862616
[TBL] [Abstract][Full Text] [Related]
14. Chemokine (c-c motif) receptor 2 mediates mechanical and cold hypersensitivity in sickle cell disease mice.
Sadler KE; Zappia KJ; O'Hara CL; Langer SN; Weyer AD; Hillery CA; Stucky CL
Pain; 2018 Aug; 159(8):1652-1663. PubMed ID: 29697532
[TBL] [Abstract][Full Text] [Related]
15. Bivalent ligand MCC22 potently attenuates nociception in a murine model of sickle cell disease.
Cataldo G; Lunzer MM; Olson JK; Akgün E; Belcher JD; Vercellotti GM; Portoghese PS; Simone DA
Pain; 2018 Jul; 159(7):1382-1391. PubMed ID: 29578946
[TBL] [Abstract][Full Text] [Related]
16. THC and gabapentin interactions in a mouse neuropathic pain model.
Atwal N; Casey SL; Mitchell VA; Vaughan CW
Neuropharmacology; 2019 Jan; 144():115-121. PubMed ID: 30312630
[TBL] [Abstract][Full Text] [Related]
17. Use of gabapentin in the treatment of chronic pain in an adolescent with sickle cell disease.
Correia CR; Soares AT; Azurara L; Palaré MJ
BMJ Case Rep; 2017 Apr; 2017():. PubMed ID: 28432164
[TBL] [Abstract][Full Text] [Related]
18. Gabapentin and NMDA receptor antagonists interacts synergistically to alleviate allodynia in two rat models of neuropathic pain.
Shi T; Hao JX; Wiesenfeld-Hallin Z; Xu XJ
Scand J Pain; 2018 Oct; 18(4):687-693. PubMed ID: 29975670
[TBL] [Abstract][Full Text] [Related]
19. Sensitization of nociceptors by prostaglandin E
Khasabova IA; Uhelski M; Khasabov SG; Gupta K; Seybold VS; Simone DA
Blood; 2019 May; 133(18):1989-1998. PubMed ID: 30796025
[TBL] [Abstract][Full Text] [Related]
20. Inhaled nitric oxide protects transgenic SAD mice from sickle cell disease-specific lung injury induced by hypoxia/reoxygenation.
de Franceschi L; Baron A; Scarpa A; Adrie C; Janin A; Barbi S; Kister J; Rouyer-Fessard P; Corrocher R; Leboulch P; Beuzard Y
Blood; 2003 Aug; 102(3):1087-96. PubMed ID: 12689931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
